Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 4, 28 April 2023
Open
Access | Article
Analysis of The Effects of Artificial Sweeteners on Diabetes and Obesity
* Author to whom correspondence should be addressed.
Abstract
With the gradual expansion of the population of diabetes and obesity, type II diabetes is more common in obese patients, and the most worrying is the increasing number of type II diabetes among adolescents and young adults. People have had to look for ways to stop or delay the onset of diabetes, and artificial sweeteners, which cause good sweetness properties and high safety without the associated high-calorie content of sugar, are widely used in the food sector as the main way to address high sugar food intake. However, despite the very widespread use of artificial sweeteners, obesity and diabetes have not been reduced as expected, and even their numbers continue to increase rapidly. In recent years, with more in-depth research on artificial sweeteners, it is gradually found that artificial sweeteners have many adverse effects on diabetes and obesity. This article describes consumers in more detail from different perspectives on the effects of artificial sweeteners and concludes that artificial sweeteners do affect insulin resistance and gut microbes, which are detrimental to diabetics and obese people. However, whether all artificial sweeteners have a significant adverse effect on the human body needs to be further investigated.
Keywords
Gestational diabetes mellitus, Insulin resistance, Older people, Artificial sweeteners, Obesity
References
1. K. M. Flegal, M. D. Carroll, B. K. Kit, et al., "Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010," Jama, 307(5), 491-497 (2012).
2. M. Ng, T. Fleming, M. Robinson, et al., "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013," The lancet, 384(9945), 766-781 (2014).
3. E. Han,L. M. Powell, "Consumption patterns of sugar-sweetened beverages in the United States," Journal of the Academy of Nutrition and Dietetics, 113(1), 43-53 (2013).
4. M. S. Mesirow,J. A. Welsh, "Changing beverage consumption patterns have resulted in fewer liquid calories in the diets of US children: National Health and Nutrition Examination Survey 2001-2010," Journal of the Academy of Nutrition and Dietetics, 115(4), 559-566. e4 (2015).
5. J. C. de Ruyter, M. R. Olthof, J. C. Seidell, et al., "A trial of sugar-free or sugar-sweetened beverages and body weight in children," New England Journal of Medicine, 367(15), 1397-1406 (2012).
6. D. F. Tate, G. Turner-McGrievy, E. Lyons, et al., "Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the C hoose H ealthy O pt i ons C onsciously E veryday (CHOICE) randomized clinical trial," The American journal of clinical nutrition, 95(3), 555-563 (2012).
7. K. Mathur, R. K. Agrawal, S. Nagpure, et al., "Effect of artificial sweeteners on insulin resistance among type-2 diabetes mellitus patients," Journal of family medicine and primary care, 9(1), 69-71 (2020).
8. J. Suez, T. Korem, D. Zeevi, et al., "Artificial sweeteners induce glucose intolerance by altering the gut microbiota," Nature, 514(7521), 181-186 (2014).
9. E. E. Canfora, R. C. Meex, K. Venema, et al., "Gut microbial metabolites in obesity, NAFLD and T2DM," Nature Reviews Endocrinology, 15(5), 261-273 (2019).
10. S. M. Jandhyala, R. Talukdar, C. Subramanyam, et al., "Role of the normal gut microbiota," World journal of gastroenterology: WJG, 21(29), 8787 (2015).
11. P. G. Farup, S. Lydersen,J. Valeur, "Are nonnutritive sweeteners obesogenic? Associations between diet, faecal microbiota, and short-chain fatty acids in morbidly obese subjects," Journal of Obesity, 2019 (2019).
12. C. L. Frankenfeld, M. Sikaroodi, E. Lamb, et al., "High-intensity sweetener consumption and gut microbiome content and predicted gene function in a cross-sectional study of adults in the United States," Annals of epidemiology, 25(10), 736-742. e4 (2015).
13. B. A. Magnuson, M. C. Carakostas, N. H. Moore, et al., "Biological fate of low-calorie sweeteners," Nutrition Reviews, 74(11), 670-689 (2016).
14. S. Chattopadhyay, U. Raychaudhuri,R. Chakraborty, "Artificial sweeteners–a review," Journal of food science and technology, 51(4), 611-621 (2014).
15. Omran, G. Ahearn, D. Bowers, et al., "Metabolic effects of sucralose on environmental bacteria," Journal of toxicology, 2013 (2013).
16. D. Sonagra, S. M. Biradar, K. Dattatreya, et al., "Normal pregnancy-a state of insulin resistance," Journal of clinical and diagnostic research: JCDR, 8(11), CC01 (2014).
17. P. G. Ovesen, J. Fuglsang, M. B. Andersen, et al., "Temporal trends in gestational diabetes prevalence, treatment, and outcomes at Aarhus University Hospital, Skejby, between 2004 and 2016," Journal of diabetes research, 2018 (2018).
18. L. L. Kurtzhals, S. K. Nørgaard, A. L. Secher, et al., "The impact of restricted gestational weight gain by dietary intervention on fetal growth in women with gestational diabetes mellitus," Diabetologia, 61(12), 2528-2538 (2018).
19. F. Nicolì, A. Prete, F. Citro, et al., "Use of non-nutritive-sweetened soft drink and risk of gestational diabetes," Diabetes Research and Clinical Practice, 178, 108943 (2021).
20. E. Szoke, M. Z. Shrayyef, S. Messing, et al., "Effect of aging on glucose homeostasis: accelerated deterioration of β-cell function in individuals with impaired glucose tolerance," Diabetes care, 31(3), 539-543 (2008).
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Biological Engineering and Medical Science (ICBioMed 2022), Part II
- ISBN (Print)
- 978-1-915371-27-0
- ISBN (Online)
- 978-1-915371-28-7
- Published Date
- 28 April 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/4/20220508
- Copyright
- 28 April 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited